Trial Profile
German Acute Hepatitis B Study: a double-blind placebo-controlled randomised two-armed parallel-group phase IIb multi-centre trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2013
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms GAHB
- 17 Apr 2007 New trial record.